FDA Delays Decision on New Alzheimer's Drug, Donanemab

FRIDAY, March 8, 2024 -- Instead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the...

  Health   Mar 8, 2024   0   97  Add to Reading List
FDA Delays Decision on New Alzheimer's Drug, Donanemab
FRIDAY, March 8, 2024 -- Instead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the...
Visit site   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow